[AAAS] BLMoverexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor每resistantBRCA-mutant ovarian cancer

sajad0922732 Post time 2024-3-27 22:07:30 | Show all posts |Read mode
Reward10points

journalㄩScience Translational Medicine

AuthorsㄩNitasha Gupta; Tzu-Ting Huang; Jayakumar R. Nair; Daniel An; Grant Zurcher; Erika J. Lampert; Ann McCoy; Ashley Cimino-Mathews; Elizabeth M. Swisher; Marc R. Radke; Christina M. Lockwood; Jonathan B. Reichel; Chih-Yuan Chiang; Kelli M. Wilson; Ken Chih-Chien Cheng; Darryl Nousome; Jung-Min Lee

Published dateㄩ2023-6-21

DOIㄩ10.1126/scitranslmed.add7872

PDF linkㄩhttps://www.science.org/doi/pdf/10.1126/scitranslmed.add7872

Article linkㄩhttp://dx.doi.org/10.1126/scitranslmed.add7872

Article SourceㄩAmerican Association for the Advancement of Science (AAAS)


Remarkㄩ

Best Answer

Please adopt

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
George Post time 2024-3-27 22:07:31 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report


Junior Member
  • post

  • reply

  • points

    30

Same Category

Latest Reply



Return to the list